Searched for
COLITIS
Sadhguru says a 100-year-old food has ‘tremendous’ healing properties, can cure IBS, strengthen immunitySpiritual leader Sadhguru and Ayurveda physician Dr. Vasant Lad revealed the profound health benefits of 100-year-old ghee, known as Shata ...- Concord Biotech shares gain 6% after USFDA approval for Tofacitinib tabletsConcord Biotech's shares surged over 6% after receiving USFDA approval for its Tofacitinib Tablets in 5 mg and 10 mg strengths. This approv...
- Tata group’s Impetis out-licenses arthritis and autoimmune drugs to VyomeIn a significant move for medical innovation, Impetis Biosciences, a subsidiary of Tata group, has teamed up with Vyome Holdings from the U...
- US market today: Biotech firm Odyssey hits nearly $900 million valuation as shares rise in Nasdaq debutOdyssey Therapeutics debuted on Nasdaq with an 11.1% surge, reaching a $899.9 million valuation. The autoimmune disease specialist successf...
- Doctors say this common diet could be worsening your IBD symptoms – find out what to avoid nowDoctors warn that diet can play a big role in inflammatory bowel disease (IBD). Eating anti-inflammatory foods like fruits, vegetables, and...
- Mankind gets CDSCO nod for Phase 1 clinical trials for molecule to treat autoimmune disordersMankind Pharma has received CDSCO approval to begin Phase 1 clinical trials for MKP11093, a molecule targeting multiple autoimmune disorder...
- Biocon Biologics secures multiple market access agreements in US for YesintekBiocon Biologics' Yesintek, a biosimilar to Stelara, has secured significant market access in the US, covering over 100 million lives. Mult...
- Biocon Biologics inks licence pact with Janssen for biosimilar productThe agreement licenses the company to launch in the US in February 2025, once approved by the US Food and Drug Administration(USFDA), Bioco...
- India sees significant increase in inflammatory bowel disease, says Lancet studyA recent study by the IBD Center of the Asian Institute of Gastroenterology (AIG) in Hyderabad, India, shows that prevalence of inflammator...
- Aurobindo Pharma subsidiary enters pact with BioFactura for biosimilar ustekinumabCuraTeQ Biologics, a wholly owned subsidiary of Aurobindo Pharma said it has entered into an exclusive license agreement with the US-based ...
- Study claims too much soybean oil can damage your gut!Researchers at the University of California, Riverside, in the US examined the gut of mice that were consistently fed a diet high in soybea...
- Biocon starts clinical study to evaluate efficacy of ItolizumabThis is a phase two randomised, double-blind, parallel-group, placebo and active-controlled (adalimumab), two treatment period study to eva...
- Former Japan PM Shinzo Abe shot in chest, showing no vital signs. Attacker arrestedThe reporter claimed to have heard 'consecutive bangs', after which Abe was seen in blood. The suspect is reportedly a middle-aged man, acc...
- Zydus Cadila gets tentative USFDA nod for generic drugThe company has received tentative approval from the US Food and Drug Administration (USFDA) for the product which is the generic version o...
- Broccoli may ward off leaky gut problemsNew York, Oct 13 (IANS) Suffering from digestive problems like leaky gut and colitis? Consuming three and a half cups of a fibrous vegetabl...
- Zydus Cadila gets USFDA nod for its ulcerative colitis drugThe company has received final approval from the USFDA for Mesalamine delayed-release tablets in the strength of 800 mg, Zydus Cadila said ...
- US court rules in favour of Zydus Cadila in patent caseThe US Court of Appeals for the Federal Circuit has affirmed judgement in favour of Zydus Pharmaceuticals (USA) Inc.
- Lupin gets FDA nod to market ulcerative colitis tablets in USThe company has received tentative approval to market its Balasalazide Disodium tablets 1.1 gm from the United States Food and Drug Adminis...
- People may inherit 'gut' bacteria that cause Crohn's diseaseScientists have shown for the first time that people may inherit some of the intestinal bacteria that cause Crohn's disease and ulcerative ...
- Glenmark enters phase II clinical trial for new drug moleculeGlenmark Pharmaceuticals said it has entered the phase II clinical trials for its new drug molecule aimed at treating ulcerative colitis.
Load More
